Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:gu ;pers:(Gustafson Deborah 1966);lar1:(gu)"

Sökning: LAR1:gu > Gustafson Deborah 1966 > Göteborgs universitet

  • Resultat 1-10 av 86
Sortera/gruppera träfflistan
  • Albani, D, et al. (författare)
  • Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva--TRELONG).
  • 2011
  • Ingår i: The Aging Male. - 1368-5538. ; 14:4, s. 257-264
  • Tidskriftsartikel (refereegranskat)abstract
    • Insulin-like growth factor 1 (IGF-1) signaling modulation has been associated with increased lifespan in model organisms, while high levels of circulating interleukin-6 (IL-6) are a marker of disability and mortality. In the prospective, population-based "Treviso Longeva"--TRELONG Study from Italy (n = 668, age range 70-105.5 years at baseline, followed for seven years) we investigated the effects of survival on the IGF-1 receptor (IGF-1R) gene polymorphism rs2229765, the IL-6 gene promoter polymorphism rs1800795, and plasma concentrations of IGF-1 and IL-6, alone or in combination. We found a sex-dependent effect for the IGF-1R rs2229765 polymorphism, as male carriers of the homozygous A/A genotype survived longer, while the IL-6 rs1800795 genotype did not influence overall or sex-specific longevity. Higher IL-6 levels were more detrimental for survival among males than females, while IGF-1 had no dose-response effect. These findings sustain the hypothesis that sex-specific longevity relies on detectable differences in genetic and biochemical parameters between males and females.
  • Andrieu, S, et al. (författare)
  • IAGG Workshop: Health promotion program on prevention of late onset dementia
  • 2011
  • Ingår i: Journal of nutrition healt & aging. - 1279-7707. ; 15:7, s. 562-575
  • Tidskriftsartikel (refereegranskat)abstract
    • IAGG, WHO, and SFGG organized a international workshop on Health promotion programs on prevention of late on-set dementia. Thirty world specialists coming from Europe, North America, Asia, South America, Africa and Australia, shared their experience on methods and results of large epidemiological interventions to reduce incidents of dementia or delay its on-set. Chaired by Laura FRATIGLIONI, an expert in Epidemiological studies on dementia issues, the workshop gave opportunity for discussions and controversies about the state-of-the-art. Based on different national and international trials (ADAPT, MAPT, FINGER, GUDIAGE, GEM etc) the questions remained opened for different aspects of methodology, the choice of domain or multi domain intervention, the choice and the definition of the target populations, the best age of candidates, the issues related to the discrepancy between late effects, and interventions' duration. We are please to publish in the Journal, the presentations presented to this workshop. These publications will complete previously task force published in the journal in the last two years on methodological issues for Alzheimer's trials including end point, biomarkers, and the experience of past therapeutic trials.
  • Arnoldussen, I. A. C., et al. (författare)
  • Obesity and dementia: Adipokines interact with the brain
  • 2014
  • Ingår i: European Neuropsychopharmacology. - 0924-977X. ; 24:12, s. 1982-1999
  • Tidskriftsartikel (refereegranskat)abstract
    • Obesity is a pandemic and a serious global health concern. Obesity is a risk factor for multiple conditions and contributes to multi-morbidities, resulting in increased health costs and millions of deaths each year. Obesity has been associated with changes in brain structure, cognitive deficits, dementia and Alzheimer's disease. Adipokines, defined as hormones, cytokines and peptides secreted by adipose tissue, may have more widespread influence and functionality in the brain than previously thought. In this review, six adipokines, and their actions in the obese and non-obese conditions will be discussed. Included are: plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6), tumor necrosis factors alpha (TNF-alpha), angiotensinogen (AGT), adiponectin and leptin. Their functionality in the periphery, their ability to cross the blood brain barrier (BBB) and their influence on dementia processes within the brain will be discussed. (C) 2014 Elsevier By, and ECNP. All rights reserved.
  • Beckman, Nils, et al. (författare)
  • Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross sectional survey of four populations, 1971-2001.
  • 2008
  • Ingår i: BMJ (Clinical research ed.). - 1468-5833. ; 337
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: To study secular trends in self reported sexual behaviour among 70 year olds. DESIGN: Cross sectional survey. Settings Four samples representative of the general population in Gothenburg, Sweden. PARTICIPANTS: 1506 adults (946 women, 560 men) examined in 1971-2, 1976-7, 1992-3, and 2000-1. MAIN OUTCOME MEASURES: Sexual intercourse, attitudes to sexuality in later life, sexual dysfunctions, and marital satisfaction. RESULTS: From 1971 to 2000 the proportion of 70 year olds reporting sexual intercourse increased among all groups: married men from 52% to 68% (P=0.002), married women from 38% to 56% (P=0.001), unmarried men from 30% to 54% (P=0.016), and unmarried women from 0.8% to 12% (P<0.001). Men and women from later birth cohorts reported higher satisfaction with sexuality, fewer sexual dysfunctions, and more positive attitudes to sexuality in later life than those from earlier birth cohorts. A larger proportion of men (57% v 40%, P<0.001) and women (52% v 35%, P<0.001) reported very happy relationships in 2000-1 compared with those in 1971-2. Sexual debut before age 20 increased in both sexes: in men from 52% to 77% (P<0.001) and in women from 19% to 64% (P<0.001). CONCLUSION: Self reported quantity and quality of sexual experiences among Swedish 70 year olds has improved over a 30 year period.
  • Besser, L. M., et al. (författare)
  • Body mass index, weight change, and clinical progression in mild cognitive impairment and alzheimer disease
  • 2014
  • Ingår i: Alzheimer Disease and Associated Disorders. - 0893-0341. ; 28:1, s. 36-43
  • Tidskriftsartikel (refereegranskat)abstract
    • The speed and severity of clinical progression after Alzheimer disease (AD) diagnosis varies and depends on multiple factors, most not well elucidated. We assessed whether body mass index (BMI) and 1-year weight change (WC) are associated with clinical progression in amnestic mild cognitive impairment (aMCI) and early-stage AD. Longitudinal data comprising 2268 aMCI and 1506 AD participants in the National Alzheimer's Coordinating Center's Uniform Data Set were used to examine nuances of clinical progression by BMI and WC, as well as potential variations in associations by age, sex, BMI (WC model), or apolipoprotein E genotype. In aMCI, high BMI (vs. moderate BMI) was associated with slower progression; weight loss (vs. no WC) was associated with faster progression. In AD, no significant differences were observed in clinical progression by BMI or WC. The association between BMI and clinical progression varied significantly by apolipoprotein E genotype in AD, and the association between WC and clinical progression varied significantly by sex and BMI in aMCI. Baseline BMI and 1-year WC in late life may serve as early prognostic indicators in aMCI and early-stage AD. If replicated, these results may help in counseling patients on anticipated clinical progression and suggest windows of opportunity for intervention.
  • Bäckman, Kristoffer, 1979-, et al. (författare)
  • 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden.
  • 2012
  • Ingår i: Journal of Alzheimer's disease : JAD. - 1875-8908. ; 28:1, s. 163-71
  • Tidskriftsartikel (refereegranskat)abstract
    • Level of adiposity is linked to dementia in epidemiological studies. Overweight and obesity in mid- and late-life may increase risk for dementia, whereas decline in body weight or body mass index (BMI) and underweight in years preceding and at the time of a dementia diagnosis may also relate to dementia. Longitudinal studies with sufficient follow-up are necessary to estimate trajectories that allow better understanding of the relationship between adiposity indices and dementia over the life course. We evaluated the natural history of BMI in relationship to clinical dementia over 37 years in the Prospective Population Study of Women (PPSW) in Sweden. PPSW is a systematic sample of 1462 women born 1908, 1914, 1918, 1922, and 1930 and aged 38-60 years at baseline. Examinations occurred in 1968, 1974, 1980, 1992, 2000, and 2005. Statistical analyses were conducted using mixed effects regression models. Trajectories of BMI over 37 years as a function of age differed between women who did versus did not develop dementia. Women developing dementia evidenced a lesser increase in BMI from age 38 to 70 years. After age 70, the BMI slope decreased similarly (no "accelerated decline") irrespective of dementia status. A lower BMI before and during dementia onset was observed. Women with similar BMI at mid-life exhibited a different pattern of BMI change as they approached late-life that was related to dementia onset. BMI may be a potential marker of dementia-related neuropathologies in the brain. Dementia is related to a common risk factor, BMI, from mid-to late-life.
  • Börjesson-Hanson, Anne, 1959-, et al. (författare)
  • Five-year mortality in relation to dementia and cognitive function in 95-year-olds.
  • 2007
  • Ingår i: Neurology. - 0028-3878. ; 69:22, s. 2069-75
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Dementia is a known predictor of mortality, but most studies include small numbers of participants above age 90. The influence of dementia or cognition on mortality in this age group is therefore uncertain. OBJECTIVE: To examine 5-year mortality in relation to dementia and cognitive performance at age 95. METHODS: A population sample of 338 individuals examined at age 95 was followed to age 100. Dementia was diagnosed according to DSM-III-R criteria. Cognitive function was measured using the Mini-Mental State Examination (MMSE). Information on severe physical disorders was obtained from the Swedish Hospital Discharge Register, and date of death from the Swedish Population Register. RESULTS: Five-year mortality was higher in 95-year-olds with dementia than in 95-year-olds without dementia (96% vs 73%; p < 0.0001), even when adjusting for severe physical disorders. A Cox regression analysis with calculation of population attributable risk (PAR), calculated from adjusted relative risks, showed that mortality was predicted by dementia (PAR 42%), cardiac disease (PAR 17%), cancer (PAR 6%), and male sex (PAR 7%), but not by stroke. Among the subjects without dementia, cognitive performance measured using the MMSE (n = 133 with complete tests; 81% of the subjects without dementia) predicted mortality. For each point increase in the MMSE, mortality decreased by 13%. CONCLUSIONS: In 95-year-olds, dementia, as well as cognitive performance in the subjects without dementia, influences mortality. When controlling for other severe medical conditions we found dementia to be the leading cause of deaths among the oldest old. The reason why dementia and cognitive function predict life expectancy requires further elucidation.
  • Börjesson-Hanson, Anne, 1959-, et al. (författare)
  • One-Month Prevalence of Mental Disorders in a Population Sample of 95-Year Olds.
  • 2011
  • Ingår i: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. - 1545-7214. ; 19:3, s. 284-91
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE:: To determine the 1-month prevalence of mental disorders among 95-year olds. DESIGN:: Cross-sectional population sample of 95-year olds. SETTING:: All 95-year olds born in the period 1901-1903 living in Gothenburg, Sweden, were invited. Elderly living in both community settings and nursing homes were included. PARTICIPANTS:: In total, 338 95-year olds (response rate: 65%) were examined (263 women, 75 men). MEASUREMENTS:: All participants were examined by psychiatrists using the Comprehensive Psychopathological Rating Scale and cognitive tests. Mental disorders were classified according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised criteria. RESULTS:: Two-third of all 95-year olds had a mental disorder. In the total sample of 95-year olds, the 1-month prevalence was 52% for dementia, 8% for depression, 4% for anxiety, and 3% for psychotic disorders. Almost one-third (29%) of the nondemented 95-year olds fulfilled criteria for a psychiatric disorder: 17% had depression, 9% anxiety, and 7% psychotic disorder. CONCLUSIONS:: The combined prevalence of mental disorders was high among 95-year olds, even after excluding dementia. These findings emphasize the importance of research, care, and detection of psychiatric problems in this age group.
  • Daborg, Jonny, et al. (författare)
  • Association of the RAGE G82S polymorphism with Alzheimer's disease
  • 2010
  • Ingår i: Journal of Neural Transmission. - 0300-9564. ; 117:7, s. 861-867
  • Tidskriftsartikel (refereegranskat)abstract
    • The receptor for advanced glycation end-products (RAGE) has been implicated in several pathophysiological processes relevant to Alzheimer's disease (AD), including transport and synaptotoxicity of AD-associated amyloid beta (A beta) peptides. A recent Chinese study (Li et al. in J Neural Transm 117:97-104, 2010) suggested an association between the 82S allele of the functional single nucleotide polymorphism (SNP) G82S (rs2070600) in the RAGE-encoding gene AGER and risk of AD. The present study aimed to investigate associations between AGER, AD diagnosis, cognitive scores and cerebrospinal fluid AD biomarkers in a European cohort of 316 neurochemically verified AD cases and 579 controls. Aside from G82S, three additional tag SNPs were analyzed to cover the common genetic variation in AGER. The 82S allele was associated with increased risk of AD (P (c) = 0.04, OR = 2.0, 95% CI 1.2-3.4). There was no genetic interaction between AGER 82S and APOE epsilon 4 in producing increased risk of AD (P = 0.4), and none of the AGER SNPs showed association with A beta(42), T-tau, P-tau(181) or mini-mental state examination scores. The data speak for a weak, but significant effect of AGER on risk of AD.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 86
fritt online (5)
Typ av publikation
tidskriftsartikel (76)
bokkapitel (4)
forskningsöversikt (4)
konferensbidrag (2)
Typ av innehåll
refereegranskat (82)
övrigt vetenskapligt (4)
Skoog, Ingmar, 1954- ... (48)
Waern, Margda, 1955- ... (25)
Östling, Svante, 195 ... (23)
Guo, Xinxin, 1972-, (17)
Blennow, Kaj, 1958-, (14)
visa fler...
Lissner, Lauren, 195 ... (9)
Bengtsson, Calle, 19 ... (8)
Björkelund, Cecilia, ... (7)
Rosengren, Lars, 195 ... (6)
Zetterberg, Henrik, ... (6)
Börjesson-Hanson, An ... (5)
Bäckman, Kristoffer, ... (5)
Sigström, Robert, 19 ... (5)
Karlsson, Björn, (4)
Kiliaan, A. J. (4)
Pantoni, Leonardo (4)
Gudmundsson, Pia, 19 ... (4)
Simoni, Michela (4)
Albani, D (3)
Ongaro, F (3)
Antuono, P (3)
Caberlotto, L (3)
Zanardo, A (3)
Siculi, M (3)
Gallucci, M (3)
Joas, Erik, 1983-, (3)
Zandi, Peter P (3)
Arnoldussen, I. A. C ... (3)
Sjögren, Magnus, (3)
Sacuiu, Simona, 1971 ... (3)
Olesen, Pernille J, (3)
Guinjoan, S. (3)
Mazzuco, S (2)
Steen, Bertil, 1938- ... (2)
Cohen, M. (2)
Mehlig, Kirsten, 196 ... (2)
Cohen, G (2)
Marlow, Thomas, (2)
Vazquez, S (2)
Campos, J (2)
Yaffe, K. (2)
Pearce, C. L. (2)
Johansson, Lena, 197 ... (2)
Scarmeas, N. (2)
Fredén Klenfeldt, Is ... (2)
Gajo, G B (2)
Durante, E (2)
Anastos, K. (2)
Golub, E. T. (2)
visa färre...
Karolinska Institutet (2)
Lunds universitet (1)
Chalmers tekniska högskola (1)
Engelska (86)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (84)
Naturvetenskap (1)
Teknik (1)
Lantbruksvetenskap (1)
Samhällsvetenskap (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy